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PEGylation is a strategy used by the pharmaceutical industry to prolong systemic circulation
of protein drugs, whereas formulation excipients are used for stabilization of proteins during
storage. Here we investigate the role of PEGylation in protein stabilization by formulation
excipients that preferentially interact with the protein.
Methodology/Principal Findings
The model protein hen egg white lysozyme was doubly PEGylated on two lysines with 5
kDa linear PEGs (mPEG-succinimidyl valerate, MW 5000) and studied in the absence and
presence of preferentially excluded sucrose and preferentially bound guanine hydrochlo-
ride. Structural characterization by far- and near-UV circular dichroism spectroscopy was
supplemented by investigation of protein thermal stability with the use of differential scan-
ning calorimetry, far and near-UV circular dichroism and fluorescence spectroscopy. It was
found that PEGylated lysozyme was stabilized by the preferentially excluded excipient and
destabilized by the preferentially bound excipient in a similar manner as lysozyme. How-
ever, compared to lysozyme in all cases the melting transition was lower by up to a few
degrees and the calorimetric melting enthalpy was decreased to half the value for PEGy-
lated lysozyme. The ratio between calorimetric and van’t Hoff enthalpy suggests that our
PEGylated lysozyme is a dimer.
Conclusion/Significance
The PEGylated model protein displayed similar stability responses to the addition of prefer-
entially active excipients. This suggests that formulation principles using preferentially inter-
acting excipients are similar for PEGylated and non-PEGylated proteins.
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Introduction
Next-generation protein drugs are proteins with altered amino acid sequence or altered
glycosylation patterns, or proteins that are covalently modified with chemical moieties such as
polyethylene glycol (PEG). These modifications are generally aimed at improving the pharma-
cokinetics of the protein, most commonly an increase in circulation half-life. In the case of
PEGylation inert PEG chains are covalently conjugated to the protein, which can then circulate
more than 20 times longer than the non-modified product depending on various protein- and
modification specific characteristics. PEGylation of proteins has led to significantly improved
possibilities for drug administration; for example, in treatment of chronic hepatitis C a 7-fold
increase in circulation half-life is observed upon PEGylation of the native protein drug [1].
This allows once-weekly injections with improved clinical outcome compared to the thrice-
weekly injections of the unmodified drug, despite the fact that receptor binding is reduced by
more than a factor 10 for the PEGylated product [2]. Currently, there are 10 PEGylated pro-
teins on the market [3].
The chemical aspects of the PEGylation process are well-documented, focusing on the dif-
ferent types of the PEGs, the coupling chemistry, the number of modifications and the target-
ing of different modification sites [4–8]. Also pharmacokinetic studies showing sustained
plasma concentrations are common [9–12].
Comparatively fewer studies are available on the physical stability of PEGylated proteins.
Those studies generally show a lower propensity for aggregation upon PEGylation, as shown
for several proteins [6, 13–15]. Somewhat surprisingly, adsorption to hydrophobic surfaces is
not reduced [13, 16]. The impact of PEGylation on thermal stability is less equivocal, with both
decreases [13, 15] and increases [17] reported.
Considering the commercial success of protein PEGylation, there is surprisingly limited lit-
erature on pharmaceutical processing and formulation aspects. A few studies on processing by
freeze-drying show that PEGylation improves stability [18–21]. While there are numerous
studies on protein formulation approaches to achieve long-term storage stability (reviewed in
[22–24]) proper formulation principles for PEGylated proteins are largely unreported in the
scientific literature although it has undoubtedly been explored by the industry. It is therefore
still unknown whether PEGylation may change the interactions between the pharmaceutical
protein and commonly used excipients. Therefore, we have investigated the interactions
between a PEGylated model protein and model excipients which are either preferentially
excluded or bound. The model protein was lysozyme (Lyz), doubly PEGylated with 5 kDa
units (LyzPEG). The preferentially excluded excipient was sucrose, which is present in various
pharmaceutical formulations, and the preferentially bound excipient was guanidine hydrochlo-
ride (GdnHCl), which is commonly used to denature proteins. It is our hypothesis that PEGy-
lation modifies the preferential interactions because PEG itself is preferentially active [25, 26].
The impact of the excipients was investigated in terms of structural stability by far- and near-
UV circular dichroism (CD), while thermal stability was characterized by thermal denaturation
using DSC, near- and far-UV CD and fluorescence. Furthermore, we discuss the spatial impli-
cations and possible interactions of PEG with the protein and possible explanations for the
observed results.
Materials
Hen egg white lysozyme dry powder (>95%), HEPES, guanidine hydrochloride and sucrose
were purchased from Sigma. 5000 Da mPEG-succinimidyl valerate (mPEG-SVA)was pur-
chased from Laysan Bio A/S.
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Experimentals
PEGylation
Lysozyme was diPEGylated with a 5 kDa mPEG-SVA onto lysine residues and purified with
IEC as described previously [13]. The diPEGylated species was used for all experiments, the
main modification sites being Lys-33 and Lys-97 [27, 28] and to a minor degree Lys-116 [29]
in the Lyz sequence.
Sample preparation
1.67 M sucrose and 2.77 M GdnHCl stock solutions with 10 mMHEPES pH 7.4 were prepared
and frozen until use. In our experience sucrose solutions may behave differently after being fro-
zen or kept at 5°C prior to use at room temperature. Therefore, both excipient solutions were
heated to 50–60°C to ensure homogeneity and then left to cool to room temperature before fur-
ther use. Excipient concentrations were determined by refractometry. The refractive index was
measured on a RL3 refractometer (Nr. 28046/01, PZOWarszawa, Warsaw, Poland). 5 mea-
surements were averaged and a buffer average subtracted. The difference in the refractive
index, Δn, is linear with the concentration of sucrose [30]. The concentration of GdnHCl con-
centration was calculated with the polynomial presented by Nozaki [31].
Protein stock solutions in 10 mMHEPES buffer pH 7.4 were diluted into the excipient solu-
tions giving final excipient concentrations of 1.0 M sucrose and 2.0 M GdnHCl. At this concen-
tration sucrose imparts a significant stabilization through preferential exclusion [32, 33]. A
concentration of 2.0 M GdnHCl was chosen because for lysozyme it is well below the denatur-
ing level [34, 35]. These excipient concentrations were used in all experiments. The protein
concentrations were 0.1–2.5 mg/ml depending on technique. LyzPEG was measured in protein
equivalent weight concentration. Concentrations were measured on a NanoDrop-1000 or a
NanoDrop-2000c Spectrophotometer (Thermo Scientific, Wilmington, Delaware). Solutions
were filtered through a 0.22 μm filter prior to DSC, CD and Fluorescence measurements.
CD
Far- and near-UV circular dichroism spectroscopy was used for two purposes: structural
assessment of Lyz and LyzPEG in buffer and in presence of excipients, and to follow tempera-
ture induced unfolding of the secondary and tertiary structure of the protein. Measurements
were performed on degassed samples using a Jasco-815 CD instrument (JASCO, Essex, UK).
The concentration was re-measured post degassing.
For recording of isothermal CD spectra for the structural assessment the instrument settings
were: 0.1 nm data interval, 1 nm band width, digital integration time (DIT) of 4 s and 20 nm/
min scan speed. 3 spectra were averaged, smoothed using a 25 point Savitzky-Golay algorithm
(2nd order), a buffer scan subtracted and the data were normalized to mean residue ellipticity
(MRE) using a molecular weight of 14306 Da. Specifically, spectra of far-UV CD were collected
at 2.5 mg/ml in a 50 μm circular quartz cuvette temperature controlled with a water bath set at
20°C. The spectra were recorded in the range 250–195 nm but are only displayed in the range
250–203 nm where the high tension always remained below 500 V. Near-UV CD were mea-
sured at a concentration of 0.4 mg/ml in a 10 mm quartz cuvette which was thermostated at
20°C using a Peltier element. The samples were recorded in the interval 320–240 nm and the
maximum high tension at 280 nm was less than 420 V in all cases.
Temperature induced unfolding was investigated by analysis of the melting curves in both
the far- and near-UV CD region. Samples were measured using rectangular quartz cuvettes
and Peltier temperature control at a protein concentration of 0.5 mg/ml using a 1°C/min ramp
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rate and a data interval of 1°C in the temperature range 20–96°C. The heating rate used here is
common for thermal unfolding analysis of proteins using DSC (see below).
The instrument parameters were set to 16 s digital integration time and the band width to
2 nm. For the temperature scans a 75 mm focusing lens was introduced in front of the sample,
yielding a light spot of approximately 1 mm x 4 mm on the sample. The relevant buffer scans
were subtracted and subsequently the data were fitted to a folded$ unfolded model in Micro-
soft Excel to obtain the temperature and the enthalpy of unfolding. Specifically, far-UV CD
melting curves were measured at 222 nm for change in backbone structure (α-helical content)
using a 1 mm cuvette (300 μl, max high tension< 530 V). Near-UV CDmelting curves were
measured at 257 nm and at 288.5 nm corresponding to the chiral activity bands of Phe and
Trp side chains. Near-UV CD was measured using a 10 mm cuvette (1000 μl, maximum high
tension< 330 V).
DSC
Differential scanning calorimetry (DSC) was conducted on a NanoDSC (cell volume 299 μl,
TA Instruments, Lindon, Utah) at 1 mg/ml of protein concentration. Heating was performed
at 1°C/min in the temperature range from 20°C to 95°C. This heating rate is commonly used
for thermal unfolding analysis of proteins in general [36] and lysozyme in particular [37–41].
Due to material restrictions we could not determine whether this scan rate was slow enough to
allow sufficient time for the LyzPEG unfolding reaction to equilibrate or perform a reversibility
assessment. Buffer scans were run until full overlay of two consecutive scans was obtained.
Samples were degassed for 10 minutes prior to loading the solutions into the cells. Buffer sub-
traction, baseline correction and data treatment (non-2-state model) were conducted with Ori-
ginPro 8.6 (OriginLab, Northampton, Massachusetts, USA).
Fluorescence
Fluorescence spectra were recorded as a function of temperature on a Spex Fluorolog 3–22
fluorescence spectrometer (Jobin-Yvon Horiba, Longjumeau, France) equipped with a 450 W
xenon lamp. 1 ml of 0.1 mg/ml protein were placed in a 10 mm quartz cuvette, covered with a
lid and stirred. Samples were excited at 295 nm and emission recorded from 300 nm to 450 nm
with an increment of 0.5 nm. Excitation and emission slits were set to 1 and 3 nm, respectively.
The data acquisition time was 0.1 s and 5 spectra were recorded and averaged at every degree
from 20°C to 96°C. The temperature was controlled by water bath circulation and the tempera-
ture was measured directly in the water bath. Between each temperature increase the equilibra-
tion time was 1 minute and the tolerance for initializing the measurement was ± 0.5°C. Buffer
scans were subtracted from the technical spectra (uncorrected for instrument characteristics)
and the data were smoothed with a 25 point Savitzky-Golay algorithm. Maximum peak analy-
ses were performed by fitting the curves to a Gaussian function around the apparent peak
maximum. Due to unexpected spectral fluctuations for the sucrose-containing solutions the
spectrum of Lyz in sucrose was fitted to a Gaussian function of the whole spectrum. The transi-
tion midpoint temperature (Tm) and enthalpy of unfolding (ΔH) were determined by fitting
the peak maxima (λmax) as a function of temperature to a 2-state model in Microsoft Excel.
GraphPad Prism 5.03 for Windows, GraphPad Software, San Diego, California, USA was used
for the Gaussian fit and graph presentation.
Structural images
The structure of Lyz was represented with PyMOL (The PyMOL Molecular Graphics System,
Version 1.7.2.3 Schrödinger, LLC) using the pdb-entry 1E8L of an NMR based solution
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structure of hen egg white lysozyme [42] to visualize the most probable PEGylation sites as
well as the protein residues relevant for evaluation of the experimental data. PoPMuSiC
2.0 [43] was used to calculate the exposure of the tryptophan residues.
Results
Secondary and tertiary structure
The impact of the PEGylation process and the effect of the two model excipients on the struc-
tural characteristics of Lyz was determined using far- and near-UV spectroscopy. The far-UV
CD spectra show that LyzPEG (Fig 1A) has a lower (85% at 205 nm) signal at the same molar
concentration as Lyz indicating a change in the secondary structure compared to the non-
PEGylated, native protein [44]. For both proteins addition of 1.0 M sucrose does not alter the
secondary structure (Fig 1B and 1C). Addition of 2.0 M GdnHCl has a marginal effect on Lyz
(Fig 1B) and a stronger effect on LyzPEG (Fig 1C). The spectral changes are primarily observed
in the region 203–235 nm, indicative of a minor loss of α-helical content.
In the near-UV region, the absorbance is dominated by contributions from the 6 Trp resi-
dues, and also includes dichroic signals of the 3 Tyr, 3 Phe and the 4 disulphide groups. Assign-
ment of the CD signals in this region is highly complex, as the chiral environment of the
chromophore plays an important role in determining magnitude and direction of the signal.
Furthermore, due to the large number of absorbing species there is a high probability of sign
cancellation. The near-UV CD spectra of the native and PEGylated protein (Fig 1D) show a
clear fine structure with 2 peaks at 300–275 nm at positive ellipticities attributed to Trp signals,
and a shoulder around 265–250 nm at negative ellipticities often attributed to Phe signals [45].
The Lyz fine structure at positive ellipticities consists of two strong bands at 294 nm and 286
nm of equal intensity and a weaker fine structure at 278 nm. The fine structure of LyzPEG is
slightly different with a diminished signal at 294 nm and a peak shift from 286 nm to 288 nm.
For Lyz the shoulder has a delicate fine structure with 2 small positive peaks at 257 nm and 264
nm which has been observed earlier in similar solution conditions [46]. For LyzPEG only the
fine structure at 257 nm remains. The LyzPEG CD signal at 257 nm is reduced compared to
Lyz, similar to the signal reduction observed in the far-UV range.
For Lyz (Fig 1E) addition of sucrose does not change the Trp spectral features, but the Phe
band gains in negative intensity confirming some type of reorganization and possible stabiliza-
tion. Addition of GdnHCl reduces the signal in the full range of the spectrum. The stabilization
of LyzPEG in presence of sucrose (Fig 1F) is only visible at the shoulder at 257 nm, and the
response to sucrose is similar to that seen for native Lyz. GdnHCl reduces the signal of LyzPEG
but to a lesser extent than for Lyz, which is opposite to the observations for the far-UV CD.
Thermal denaturation
Thermal denaturation of Lyz and LyzPEG with and without excipients was followed by DSC,
far-UV CD at 222 nm and near-UV CD at 257 nm (Phe) and 288.5 nm (Trp).
The DSC thermograms were fitted to a non-2-state model after subtraction of a cubic baseline.
Lyz fit well to a 2-state model, while LyzPEG did not. A satisfactory fit of LyzPEG was obtained
with a non-2-state model and as Lyz unfolding is reversible [47–49], reversibility was also
assumed for LyzPEG. Material restrictions prevented reversibility assessment and elucidation of
potential scan rate dependency and consequently the calculated thermodynamic parameters
must be taken with due caution and are only meant for qualitative comparisons. For consistency
and comparability both Lyz and LyzPEG were fitted to a non-2-state model. Similar values were
obtained for Lyz using the 2 models and a simple analysis of area under the curve (corresponding
to the calorimetric enthalpy) and apparent melting temperature (Tmax instead of Tm) for all
Preferential Interactions and the Effect of Protein PEGylation
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samples gave similar values (S2 Table) to the ones obtained with the non-2-state model. The
obtained values for Tm and enthalpies are represented in Fig 2 and Table 1 (Tm values in S1
Table). Although the Tm values are often used as an indication of protein thermodynamic stabil-
ity at room temperature [50–52], the correct approach would be to compare Gibbs free energy
(ΔG) of the two proteins at physiologically relevant temperatures. This requires knowledge of the
heat capacity change upon unfolding (ΔCP), which can be obtained directly from the DSC
Fig 1. Far- and near- UV CD spectra measured at 20°C, pH 7.4 in HEPES buffer. Excipients are 1.0 M sucrose and 2.0 M GdnHCl. (A-C) Far-UV CD
spectra of (A) Lyz and LyzPEGwithout excipients, (B) Lyz with excipients and (C) LyzPEGwith excipients; (D-F) near-UV CD spectra of (D) Lyz and LyzPEG
without excipients, (E) Lyz with excipients and (F) LyzPEG with excipients.
doi:10.1371/journal.pone.0133584.g001
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thermograms [53]. Unfortunately, this was not possible in our case, due to uncertainty in draw-
ing the post-denaturational baselines, which were affected by the post-denaturational aggregation
of lysozyme [47]. However, an estimate of the ΔCP can be made from the mutual dependence
between ΔHcal and Tm (S5 Fig). The CD results were fitted to a simple folding-unfolding model
Fig 2. Melting transition temperatures and changes as a function of excipient presence. Blue: DSC
non-2-state fit, red: far-UV CD at 222 nm (α-helical content) and green: near-UV CD global fit of 257 nm (Phe
signal) and 288.5 nm (Trp signal). The figures show A) melting transition temperatures. B) Sucrose induced
change in melting transition temperatures. C) GdnHCl induced change in melting transition temperatures.
doi:10.1371/journal.pone.0133584.g002
Preferential Interactions and the Effect of Protein PEGylation
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in Excel as described in the literature [54]. The near-UV CD data at 257 nm and 288.5 nm were
fitted globally as well as individually and the results of the individual fits are available in S3 Table.
The LyzPEG CD data fit equally well to a dimer model (S3 Fig, see also discussion below). In all
cases the heat capacity change was fixed to 0 as the fitting quality was not improved upon intro-
duction of non-zero ΔCp. Melting curves and their respective fits can be found in the S1 Fig and
S2 Fig, the resulting Tm and enthalpies are shown in Fig 2 and Table 1.
The CD and fluorescence derived enthalpies correspond to the DSC derived van’t Hoff
enthalpies. Near-UV CD is a global fit of 257 nm and 288.5 nm. Fluorescence peak maximum
revealed that Lyz in sucrose had an additional transition at 50°C with ΔH = 495 kJ/mol.
DSC
The DSC data provided an estimate for the Tm value for Lyz at 73.5°C and 1.6°C lower for Lyz-
PEG at 71.9°C. In the presence of sucrose the Tm of Lyz is shifted to 79.0°C, an increase of
5.5°C, and in the presence of GdnHCl the Tm is decreased by 16.9°C to 56.6°C. LyzPEG shows
similar melting temperature shifts as Lyz in response to the addition of excipients, although all
melting temperatures are lower than those for Lyz. In sucrose LyzPEG has a Tm of 76.3°C,
which is a stabilization of 4.4°C, and GdnHCl lowers the LyzPEG Tm to 56.3°C, which is a
decrease of 15.6°C. The transition midpoint temperatures are presented graphically in Fig 2A
and the differences in Tm values as a function of sucrose and GdnHCl are presented in Fig 2B
and 2C, respectively.
The calorimetric melting enthalpy (ΔHcal) of Lyz is 405 kJ/mol which corresponds reason-
ably well with previous studies [55]. For LyzPEG, however, the calorimetric enthalpy is less
than half (175 kJ/mol) of that value, while the ratio of van‘t Hoff enthalpy (ΔHvH) to calorimet-
ric enthalpy ΔHcal is ca. two, suggesting that LyzPEG unfolds as a dimer. For Lyz the ΔHcal
and ΔHvH, were essentially the same consistent with Lyz being a monomer. All ΔHcal, ΔHvH
values and ΔHvH/ΔHcal ratios are summarized in Table 1. With ΔHcal = 481 kJ/mol sucrose
clearly stabilizes Lyz, but for LyzPEG the addition of sucrose decreases ΔHcal to 156 kJ/mol.
The denaturant GdnHCl reduces the calorimetric melting enthalpy to 306 kJ/mol and 112 kJ/
mol for Lyz and LyzPEG, respectively, which means both proteins are destabilized to the same
extent. The ΔHvH/ΔHcal ratios suggest that LyzPEG stays dimeric in the presence of both
excipients.
Tm and ΔHcal obtained from the DSC data in all three solution conditions were used to
calculate the heat capacity change upon unfolding, ΔCp, of Lyz and LyzPEG (S5 Fig). This
approach gives ΔCp of 7.35 kJ/(Kmol) and 2.68 kJ/(Kmol) for the Lyz and LyzPEG, respec-
tively. The ΔCp for Lyz compares well with earlier studies [39, 56]. The ΔCp for LyzPEG is
lower by more than a factor 2, which is in agreement with the decreased overall structure of the
PEGylated protein observed by CD. The heat capacity change upon unfolding was then used to
Table 1. Enthalpy of unfolding from various techniques.
Method DSC (non-2-state) Far-UV CD Near-UV CD Fl λmax
Parameter ΔHcal (kJ/mol) ΔHvH (kJ/mol) ΔHvH/ΔHcal ΔH (kJ/mol) ΔH (kJ/mol) ΔH (kJ/mol)
Lyz
No excipients 405 481 1.2 404 562 442
Suc 481 472 1.0 510 553 458
GdnHCl 306 363 1.2 314 380 400
LyzPEG
No excipients 175 372 2.1 248 286 -
Suc 156 398 2.5 167 348 -
GdnHCl 112 294 2.6 239 276 -
doi:10.1371/journal.pone.0133584.t001
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estimate the Gibbs free energy function for both proteins using the modified Gibbs-Helmholtz
equation, and as anticipated the LyzPEG was less stable at all temperatures between 0°C and
Tm compared to Lyz. At room temperature the ΔG value of LyzPEG was about half of that of
the native Lyz (S5 Fig).
CD
Thermal denaturation studies by CD show similar trends as the DSC analysis (Fig 2 and
Table 1). For the far-UV CD melting the Tm values are ca. 1–4°C lower than those measured by
DSC for both proteins and in all solution conditions. In sucrose the Tm of Lyz increases by
5.1°C, similar to that observed by DSC, and the LyzPEG Tm increases by 2.5°C, almost half of
that observed by DSC. In the presence of GdnHCl the far-UV CD Tm is decreased ca. 2°C fur-
ther for both proteins compared to DSC.
In near-UV CD the changes for both Lyz and LyzPEG also occur at a lower temperature
than measured by DSC. The Tm values are also lower than in the far-UV CD experiments
except in the presence of GdnHCl, where a slightly higher Tm is observed as compared to that
determined by far-UV CD.
The melting enthalpy for Lyz determined from the far-UV CD is lower than that observed
by DSC, while the melting enthalpy for Lyz in presence of both excipients agrees better with
the DSC data (Table 1) under both solution conditions. ΔH for LyzPEG is also lower than
expected when comparing to the DSC ΔHvH value. The addition of sucrose to LyzPEG appar-
ently decreases the melting enthalpy, whereas this remains almost constant in the DSC data.
Upon addition of GdnHCl the LyzPEG far-UV CD melting enthalpy remains the same as in
buffer, and is twice as high as the corresponding ΔHcal.
The melting enthalpies calculated from the near-UV CD are generally higher for both modi-
fied and unmodified proteins compared to DSC and far-UV CD. The only exception is that
LyzPEG near-UV CDmelting enthalpies are lower compared to the DSC van’t Hoff enthalpies.
For Lyz the addition of sucrose does not change the enthalpy. Addition of GdnHCl reduces the
enthalpy to the same extent as observed with DSC and far-UV CD. The near-UV CD enthalpy
for LyzPEG in buffer is half that of Lyz. It is a bit higher than the far-UV CD enthalpy, much
higher than the ΔHcal, but lower than the ΔHvH. Excipients exert a different effect on LyzPEG
compared to Lyz: for LyzPEG the enthalpy is greatly increased by addition of sucrose, whereas
addition of GdnHCl has no effect. The latter was also observed with far-UV CD. S1 Text con-
tains a more elaborate discussion on data quality, including explanations for the apparent dis-
crepancies in the enthalpy values obtained by the different techniques.
Fluorescence
Characterization of the temperature-induced unfolding was also attempted using fluorescence
spectroscopy. Lyz displays a clear melting transition (Fig 3A) while LyzPEG merely shows a
gradual redshift during heating (Fig 3B) which does not allow calculation of the denaturation
parameters. The ΔH (Table 1) and Tm values of Lyz correspond well with the calorimetric data.
The melting points of Lyz are 75.2°C, 79.7°C and 56.6°C for no excipient, sucrose and GdnHCl
containing solutions, respectively. An additional minor transition at 50°C is observed for Lyz
in sucrose.
The fluorescence traces of the LyzPEG solutions lack clear melting transitions and the λmax
values are consistently red shifted by 5–7 nm throughout the whole temperature range com-
pared to Lyz, indicating an increased solvent exposure of the active tryptophans.
Preferential Interactions and the Effect of Protein PEGylation
PLOS ONE | DOI:10.1371/journal.pone.0133584 July 31, 2015 9 / 18
Discussion
Structural features exploited in lysozyme
Lysozyme is a very-well characterized protein and the 3D structure has been determined both
in solution by NMR and in crystal form by protein X-ray crystallography. Fig 4 depicts the
structure of Lyz from Schwalbe et al. [42], with the two lysines that are most likely PEGylated
marked in yellow. The fold of the protein is characterized by two sub-domains, α and β. The
α-domain consists of a 310-helix and 4 α-helices (res. no. 1–35 and 85–129), and the β-domain
is composed of a short triple-stranded antiparallel β-sheet, a loop and a 310-helix (res. no. 36–
84). The α-domain is stabilized by a hydrophobic core. Additionally, 4 disulphide bonds play
an important role for the stabilization of the tertiary and secondary structure [57]. There is a
general consensus that Lyz unfolds in a 2-state unfolding process [58, 59] although some
studies have suggested a more complicated unfolding process at low pH [53]. Of spectroscopic
relevance there are 6 Trp and 3 Tyr and 3 Phe units in the native protein. The bulk of Lyz fluo-
rescence is attributed only to Trp residues 62 and 108 (Fig 4, marked in green) [60]. The acces-
sible surface area (ASA) calculated by PoPMuSiC shows that in the native state the side chain
of Trp-62 is somewhat solvent-exposed (ASA = 42%) while Trp-108 is buried (ASA = 5.7%).
Emission from the other Trp units is likely quenched by nearby cystine groups [60, 61].
Effect of PEGylation
All analytical techniques used in the current study indicate that our PEGylated lysozyme has
an altered conformation and stability compared to the native lysozyme, which corresponds to
our earlier finding [13]. The far- and near-UV CD spectra indicate a loss of α-helical structure
in PEGylated protein and some local changes around the Trp residues. As depicted in Fig 4
both PEG-chains are attached to α-helical motifs which may destabilize the implicated helices
resulting in a reduced α-helix signal. A reduced far-UV CD signal has been observed before for
LyzPEG monoPEGylated at Lys-33 [28].
The thermal denaturation studies show both a reduced thermal stability of LyzPEG, indi-
cated by a lower melting temperature, and a reduced thermodynamic stability, with the ΔGu
value at 25°C being about half of that found for Lyz, suggesting that the LyzPEG is not fully
folded. The latter is reflected in the lower enthalpy of denaturation at the Tm and the dimin-
ished Gibbs free energy function in the temperature range of 0°C—Tm (S5 Fig). While
Fig 3. Peakmaximum of fluorescence spectra as function of temperature and excipient. A) Lyz B) LyzPEG.
doi:10.1371/journal.pone.0133584.g003
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denaturation of the native lysozyme is consistent with the 2-state model, the DSC melting pro-
file of LyzPEG can only be fitted to the non-2-state model, indicating a change in the denatur-
ation mechanism of LyzPEG. Unfortunately, material limitations prevented further elucidation
of the unfolding mechanism and the potential contribution of kinetically controlled events.
This introduces an uncertainty in the validity of the thermodynamic analysis, which in turn
Fig 4. Ribbon structure of hen egg white lysozyme (pdb entry 1E8L). The PEGylated lysines are indicated in yellow and the fluorescence active
tryptophans are indicated in green. The sequence of lysozyme is given below the structure with the same color indications for the mentioned lysines and
tryptophans.
doi:10.1371/journal.pone.0133584.g004
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means the results can only be used for qualitative comparative purposes. The ratio of van‘t
Hoff to calorimetric enthalpy of 2:1 (Table 1) suggests that the PEGylated protein forms a
dimer. At the same time, the total calorimetric enthalpy of LyzPEG is lower, indicating that the
energy of dimerization is insufficient for compensating the enthalpy loss from the partial
unfolding. The dimeric nature of LyzPEG is supported by the small-angle X-ray scattering
studies reported in our previous publication [13]. However, fitting the melting curves of Lyz-
PEG to a model where the protein unfolding is coupled to dimer dissociation was unsuccessful,
failing to reproduce the sharp shape of the LyzPEG denaturation transition. Inability of the
dimer-denaturation model to properly describe DSC data could be due to the fact that this
model does not take into account the partially denatured starting state of LyzPEG. In addition,
it is unclear to what extent the potential interference from the PEG moiety could affect the
shape of the DSC profile. In contrast, the dimer-denaturation model described the CD data
very well, indicating that the spectroscopic techniques were insensitive to the selection of the
fitting model as both monomer and dimer fitting results were of equally good quality.
The fluorescence spectroscopic analysis of LyzPEG spectra shows a significant red-shift of
the peak maximum suggesting increased solvent exposure of the fluorescent tryptophans. This
is another indication of the partially denatured initial state of LyzPEG with a consequent expo-
sure of Trp residues that are normally buried in the native Lyz. In addition, the absence of a
clear transition in the LyzPEG fluorescence melting data suggests that the local environment
around the tryptophans is already disrupted at room temperature, so that increasing tempera-
tures lead only to the gradual shifts in Trp fluorescence properties.
Another potential explanation for the altered fluorescent properties of LyzPEG is the pres-
ence of PEG. It is unlikely that the dimer formation causes a quenching of the two active tryp-
tophans by cysteine groups of the neighboring protein. Such a quenching would have reduced
the overall fluorescence intensity, but the fluorescence intensity was found to be constant
within the concentration uncertainties for all solutions (S4 Fig). Furness et al. found that the
cleft between the α- and β-domain is a binding site for free 4 kDa PEG [62]. Both Trp-62 and
Trp-108 are positioned close to the cleft and thus close proximity to PEG could shield or inter-
fere with the spectroscopic changes during unfolding.
Effect of sucrose
Addition of the preferentially excluded excipient sucrose to Lyz and LyzPEG has no impact on
the secondary structure, and a minor effect on the tertiary structure of the protein, as indicated
by far- and near-UV CD spectra, respectively (Fig 1). This minor effect is not unexpected, as
the preferential exclusion of sucrose is known to reduce the structural flexibility of a protein
[63] without affecting the secondary structure [64]. As also expected, the addition of sucrose
resulted in increased Tm values [32, 40, 65]. This increase (Fig 2B), 5–6°C for Lyz, and 2.5–5°C
for LyzPEG, is observed in all techniques used. The large variability of the change in Tm for
LyzPEG is unexpected, with the Tm determined by far-UV CD (222 nm) responsible for the
low extreme. We have no unequivocal explanation for this variability, but it may be due to the
dimeric nature of the LyzPEG and the associated complex unfolding process. The effect of
sucrose on the LyzPEG appears to have the largest impact on the tertiary fold around some Phe
residues, as suggested by the relatively large change in the near-UV CD spectrum around 257
nm. The relative change in van’t Hoff enthalpy as a result of excipients (Fig 5) is fairly constant
for Lyz with no ΔHvH change in the sucrose solution, except in far-UV where it is higher.
The changes in enthalpy of unfolding for LyzPEG are more variable (Fig 5), with a slightly
increased van’t Hoff enthalpy, a strong decrease for the far-UV data and an increase for the
near-UV data. This variability could be due to the lower transition enthalpies of the LyzPEG
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and concomitant larger noise levels that impacted the fitting. As noted earlier, an increase for
the unfolding enthalpy is expected upon addition of a preferentially excluded excipient [33,
66], and in principle this should be observed irrespective of the protein folding characteristic
that is being followed. In summary, our data do not show any unequivocal differences of the
impact of sucrose on the thermal stability between Lyz and LyzPEG.
Effect of GdnHCl
Lyz denaturation by GdnHCl is known to be pH dependent. At room temperature and neutral
pH Lyz starts to unfold at GdnHCl concentrations around 3 M [34, 35], at pH 4–6 it is dena-
tured above 2 M [67–70] and 2 M is sufficient to start denaturing Lyz below pH 4 [49, 71].
Thus, at the pH used in this study (7.4) no significant unfolding is expected. This is confirmed
by the far- and near-UV CD (Fig 1), which show no change in the Lyz secondary structure,
minor changes in the Lyz tertiary structure, and also minor changes in the secondary and ter-
tiary structure of LyzPEG. As anticipated, GdnHCl does have a destabilizing effect, as shown
by the significant reduction in unfolding temperature. In our case the Lyz Tm is decreased by
ca. 16.5–18.5°C and the LyzPEG Tm is decreased a bit less by 14.5–18.0°C (Fig 2C). As expected
upon a decrease in melting temperature, the unfolding enthalpy is reduced by a fourth for
Lyz in the presence of GdnHCl (Fig 5) in both DSC, far- and near-UV CD. For LyzPEG this
is not the case. A similar reduction is observed in ΔHvH, but there are no changes for the far-
UV or near-UV CD analyses. The DSC results suggest that LyzPEG responds similarly to
GdnHCl as Lyz. While there are some inconsistencies between CD spectral data and CD ther-
mal denaturation data both for far- and near-UV CD on the effect of GdnHCl, these are small.
In conclusion, GdnHCl also does not cause any major difference in behavior of Lyz versus
LyzPEG.
Fig 5. Relative change in enthalpy of unfolding upon excipient addition. Yellow: DSC calorimetric
enthalpy from non-2-state fit, Blue: DSC van’t Hoff enthalpy from non-2-state fit, red: far-UV CD at 222 nm (α-
helical content) and green: near-UV CD global fit of 257 nm (Phe signal) and 288.5 nm (Trp signal). The
LyzPEG ratios are calculated based on lower absolute values (see Table 1) likely with a larger impact of
fitting uncertainty and thus resulting in an apparent larger variation.
doi:10.1371/journal.pone.0133584.g005
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Conclusion
Overall, our results show that within the limits of the different methods PEGylation of lyso-
zyme has no, or a minor, impact on the preferential interaction with our model excipients. The
preferential exclusion of sucrose and preferential binding of GdnHCl are somewhat lower for
LyzPEG, as shown primarily by the change in melting temperature, but this may well be a
result of the altered folding of LyzPEG caused by the PEGylation itself. Thus, the thermody-
namic stabilization and destabilization of PEGylated proteins by preferentially active excipients
is likely similar to that observed for the unmodified protein. This then means that PEGylated
proteins can be stabilized using the same preferential interaction formulation principles as
used for non-PEGylated proteins. Further experiments including multiple proteins should be
performed to support this conclusion.
Supporting Information
S1 Fig. DSC results and fitting. The first row shows raw data (insert: protein and buffer) as
well as the data with buffer subtracted and the cubic baseline to be subtracted before fitting.
The second row shows area under the curve (AUC) which is comparable with the enthalpy
(only this number is based on the true data whereas ΔH is based on the fit of the data). The 3rd
row shows the simplest fitting model: a 2-state fit (data in black, fit in red). The fit is very poor
for LyzPEG in GdnHCl and these values were therefore not used. The 4th row shows the fit to a
non-2-state model and the Tm values are listed in S2 Table. It was not possible to fit LyzPEG in
presence of sucrose to a 2-state model.
(PDF)
S2 Fig. CD melting curves (buffer subtracted) and fitting to a 2-state model where ΔCp = 0.
1st row shows far-UV CDmelting at 222 nm corresponding to the change in secondary struc-
ture (especially α-helix content). The 2nd row shows near-UV CDmelting at 257 nm corre-
sponding to the phenylalanine signal. The 3rd row shows near-UV CDmelting at 288.5 nm
corresponding to the Trp fine structure. The 4th row shows the global fit of the two near-UV
CD data sets. The Tm-values for the far-UV and global fit of near-UV data are presented in S1
Table. The Tm and ΔH values for the individual near-UV fit are presented in S3 Table.
(PDF)
S3 Fig. Global fit of near-UV CD data (257 nm and 288.5 nm) of LyzPEG to a dimer model.
A) no excipients B) 1.0 M sucrose C) 2.0 M GdnHCl. For the simple monomer unfolding
model the transition midpoint temperature (Tm) coincides with the temperature, where the
change in Gibbs free energy is equal to 0 (TΔG = 0). In case of the dimer unfolding model the fit-
ted TΔG = 0 values are higher than the Tm values [57]. However, inspection of the fit indicates
that population of the denatured state becomes 50% at the temperatures close to the Tm values
calculated from the monomer unfolding model.
(PDF)
S4 Fig. Fluorescence spectra of Lyz and LyzPEG in HEPES buffer pH 7.4 at 20°C. The
graphs demonstrate the apparent red-shift in LyzPEG whereas the fluorescence intensity
remains the same.
(PDF)
S5 Fig. Gibbs free energy function, calculated with the help of ΔCp values obtained from
the slope of ΔHcal vs Tm dependence. The insert shows the thermodynamic parameters used
for ΔCp determination. ΔG was calculated using the modified Gibbs-Helmholtz equation as
described in Vaz DC, Rodrigues JR, Sebald W, Dobson CM, Brito RMM. Enthalpic and entropic
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contributions mediate the role of disulfide bonds on the conformational stability of interleukin-4.
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S1 Table. Melting transition temperatures from DSC and CD with Lyz and LyzPEG in vari-
ous solution conditions. Values are presented graphically in Fig 2A in the article.
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S2 Table. DSC results of values obtained with different models. Integration was performed
using a linear baseline while the 2-state and non-2-state were fitted using a cubic baseline as
seen in S1 Fig. Integration results are AUC which is comparable to ΔH and Tmax which is com-
parable to Tm. Lyz fitted well to a 2-state model and are included here. Values from the non-
2-state fit presented in the article are included here for comparison.
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S3 Table. Near-UV CD 2-state fit of single data sets recorded at 257 and 288.5 nm.
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